Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

September 15, 2020
Review

Clinical practice to address tamoxifen nonadherence

Breast Cancer Research and Treatment
Richard R LoveAndrea M Straus
September 14, 2020

FDG-PET/CT in high-risk primary breast cancer-a prospective study of stage migration and clinical impact

Breast Cancer Research and Treatment
Marianne VogsenMalene Grubbe Hildebrandt
September 18, 2020

Bone-protective and anti-tumor effect of baicalin in osteotropic breast cancer via induction of apoptosis

Breast Cancer Research and Treatment
Bangmin WangHong Ge
September 12, 2020

Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors

Breast Cancer Research and Treatment
Pietro SollenaEuropean Network for Cutaneous ADverse event of Oncologic drugs (ENCADO) group
September 18, 2020

Metformin and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancer

Breast Cancer Research and Treatment
Lei XueSao Jiralerspong
September 17, 2020

Long-term survival outcomes of repeat lumpectomy for ipsilateral breast tumor recurrence: a propensity score-matched analysis

Breast Cancer Research and Treatment
Soo Yeon BaekSae Byul Lee
September 11, 2020

Utility of 70-kV single-energy CT in depicting the extent of breast cancer for preoperative planning

Breast Cancer Research and Treatment
Marehiko HisoshimaYuta Shibamoto
September 12, 2020

Pre-diagnostic allostatic load and health-related quality of life in a cohort of Black breast cancer survivors

Breast Cancer Research and Treatment
Cathleen Y XingAdana A M Llanos
September 16, 2020
Review
Open Access

Managing therapeutic resistance in breast cancer: from the lncRNAs perspective

Theranostics
Liyuan PengNa Xie
September 18, 2020

Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center

Breast Cancer Research and Treatment
Katya LoskTari A King
September 10, 2020
Review
Open Access

Progression-Free Survival and Overall Survival of CDK 4/6 Inhibitors Plus Endocrine Therapy in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis

International Journal of Molecular Sciences
Michela PiezzoMichelino De Laurentiis
September 12, 2020

Phytochemicals as PI3K/ Akt/ mTOR Inhibitors and Their Role in Breast Cancer Treatment

Recent Patents on Anti-cancer Drug Discovery
Arunaksharan Narayanankutty
September 16, 2020

Body mass index (BMI) and benefit from adjuvant chemotherapy in breast cancer: is it enough?

Breast Cancer Research and Treatment
Michela PalleschiChiara Casadei
September 12, 2020
Review

Impalpable breast lesion localisation, a logistical challenge: results of the UK iBRA-NET national practice questionnaire

Breast Cancer Research and Treatment
Santosh K SomasundaramJames Harvey
September 14, 2020
Open Access

P-cadherin induces anoikis-resistance of matrix-detached breast cancer cells by promoting pentose phosphate pathway and decreasing oxidative stress

Biochimica Et Biophysica Acta. Molecular Basis of Disease
Bárbara SousaJoana Paredes
September 15, 2020

Down-regulation of FOS-like antigen 1 enhances drug sensitivity in breast cancer

International Journal of Clinical and Experimental Pathology
Lingdi DuanWei Dong

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

© 2020 Meta ULC. All rights reserved
/feed-previews/breast-cancer-chemo-resistance/82d7d105-0cf8-4832-8e54-dfc4ae3b27fb